In a new study, researchers examined four randomized controlled trials of belimumab (Benlysta®) to gain a better understanding of systemic lupus erythematosus (SLE) active disease progression with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback